Patents Assigned to PAD Pharma Limited
  • Treatment of protein aggregation diseases
    Patent number: 8383617
    Abstract: A method of treatment for the prevention or therapy of a protein aggregation disease includes the administration in combination of a first active medicament and a second active medicament, wherein the first active medicament is active to impede aggregation of amyloid protein and the second active medicament is active to disaggregate previously formed aggregates of amyloid protein.
    Type: Grant
    Filed: January 30, 2008
    Date of Patent: February 26, 2013
    Assignee: PAD Pharma Limited
    Inventors: Stuart Mark Wilson, Christopher John Stanley
  • TREATMENT OF PROTEIN AGGREGATION DISEASES
    Publication number: 20100035859
    Abstract: A method of treatment for the prevention or therapy of a protein aggregation disease includes the administration in combination of a first active medicament and a second active medicament, wherein the first active medicament is active to impede aggregation of amyloid protein and the second active medicament is active to disaggregate previously formed aggregates of amyloid protein.
    Type: Application
    Filed: January 30, 2008
    Publication date: February 11, 2010
    Applicant: PAD Pharma Limited
    Inventors: Stuart Mark Wilson, Christopher John Stanley